Clinical trial
Aldosterone Antagonism and Microvascular Function
NCT01887119 · Maastricht University Medical Center, Other · Terminated
Key facts
| NCT number | NCT01887119 |
|---|---|
| Title | Aldosterone Antagonism and Microvascular Function |
| Official title | Effects of Aldosterone Antagonism on Insulin-mediated Microvascular Function in Subjects With the Metabolic Syndrome |
| Lead sponsor | Maastricht University Medical Center, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Abdominal Obesity Metabolic Syndrome, Insulin Resistance, Hypertension |
| Intervention type | Drug, Other |
| Interventions | Eplerenone, Placebo |
| Enrollment | 25 |
| Start date | Oct 1, 2013 |
| Primary completion | Nov 1, 2018 |
| Completion | Nov 1, 2018 |
| First posted | Jun 26, 2013 |
| Last update posted | Nov 5, 2018 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: